Optimization of large-scale production process for human prothrombin complex concentrates
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 12
Abstract
Objective To determine the optimal process conditions for efficiently extracting human prothrombin complex concentrates from human plasma. Methods Using human plasma as the materials and the yield of prothrombin complex concentrates as the evaluation standard, the preparation process parameters were studied and optimized through design of exporement(DOE), orthogonal experiments, and single factor experiments. Results The optimal process conditions were as follows: DEAE Sephadex A50 gel was selected, which balanced to pH 7.6, and then the amount of 1.7-2.5 g/L of plasma weight is added into the cryoprecipitate supernatant for adsorption for 40 minutes; Washing solution (0.15-0.175 mol/L sodium chloride) with 3 times the volume of gel was washed 3 times, and eluent (0.5-2.0 mol/L sodium chloride) was washed 3 to 5 times; Add stabilizer (heparin 35 IU, sodium chloride 0.1 mol/L) for ultrafiltration dialysis. Conclusion By using the optimized process mentioned above, the yield(measured by human coagulation factor IX)can reach 620 000 to 630 000 IU/ton of plasma, which is suitable for large-scale production.
Authors and Affiliations
Liangchao ZHAO, Guanjun LI, Xiaowei MA, Dongsheng ZHAO, Minghua WNAG, Bo SONG
Keywords
Related Articles
- EP ID EP738724
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.12.015
- Views 42
- Downloads 0
Molecular mechanism and bioinformatics analysis of 9 samples with rare RhD variants
Objective To study the molecular mechanism of 9 samples with rare RhD variants and their RhD epitopes and protein structure. Methods The 9 blood samples with rare RhD variants were collected from 210 644 blood donors of...
Expert consensus on RhD blood group testing strategies in blood transfusion compatibility testing laboratories
RhD antigen is the most immunogenic antigens in the Rh blood group system and can cause hemolytic transfusion reactions (HTRs) and severe hemolytic disease of the fetus and newborn (HDFN). RhD-negative red blood cell (RB...
Preparation quality control and clinical application observation of pooled platelets with leukocytes reduced
Objective To investigate the preparation quality and clinical application effect of pooled platelets with leukocytes reduced. Methods The quality and clinical effect of the buffy-coated method prepared pooled platelets l...
Expert consensus on testing of killer-cell immunoglobulin-like receptor genes
The killer-cell immunoglobulin-like receptor(KIR) gene family exhibits complex genetic diversity. In addition to allele level polymorphisms, KIR genes show extra diversity at haplotype content as well as copy number vari...
Distribution frequencies of KIR genes among the Korean, Manchu and Han ethnic groups in Jilin Province
Objective To provide foundational data for exploring the association between KIR genes and diseases by analyzing the frequency and polymorphism of killer-cell immunoglobulin-like receptor (KIR) genes in Han, Manchu and K...